Citations as recorded by:

1. Viability of pegIFNα-RBV for CHC in the direct acting antiviral era: a practical algorithm between efficacy and cost containment

Journal of Chemotherapy, 2017, 29(2) p. 94

DOI: 10.1080/1120009X.2016.1171467

Citations as recorded by: Cross Ref Google

2. Differential Antiviral Effects of Pegylated Interferon-α2a and Pegylated Interferon-α2b in Chronic Hepatitis C

Clin Drug Investig, 2014, 34(12) p. 871

DOI: 10.1007/s40261-014-0241-y

Citations as recorded by: Cross Ref Google

3. Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population

BMC Gastroenterol, 2013, 13(1)

DOI: 10.1186/1471-230X-13-74

Citations as recorded by: Cross Ref PMC Google